Senior Manager, Clinical Supply Chain
Abata TherapeuticsFull Time
Senior (5 to 8 years), Expert & Leadership (9+ years)
Cambridge, Massachusetts, United States
Key technologies and capabilities for this role
Common questions about this position
A BS/BA or equivalent in operations, life sciences, or a health-related field is required, along with a minimum of 3 years of experience in the pharmaceutical/biotechnology industry focused on clinical supply chain or clinical trial material management. Experience with primary and secondary packaging, labeling, distribution, recall processes, and regulatory requirements for clinical trial materials is also needed.
The role requires strong analytical, organizational, and communication skills, the ability to manage multiple tasks in a dynamic environment, a strong understanding of cGMPs, FDA, and EU regulations, and experience managing CMO contracts and vendor relationships.
This information is not specified in the job description.
This information is not specified in the job description.
Strong candidates will have at least 3 years of direct experience in clinical supply chain or trial material management in pharma/biotech, hands-on knowledge of packaging, labeling, distribution, and regulatory compliance, plus proven skills in vendor management and cross-functional collaboration.
Biotech company focused on drug discovery
Relay Therapeutics focuses on drug discovery by studying protein motion to develop new treatments for complex diseases. Their main tool, the Dynamo™ platform, uses both experimental and computational methods to identify potential drug candidates, especially for conditions that are hard to treat with current therapies. This platform allows them to target proteins that have previously been difficult to address, particularly in areas like precision oncology and genetic diseases. Unlike many competitors, Relay Therapeutics emphasizes the importance of protein dynamics in their research, which sets them apart in the biotech field. Their goal is to create effective medicines that can significantly improve patients' lives, and they are actively conducting clinical trials to ensure the safety and effectiveness of their drug candidates.